In vitro evaluation of vascular endothelial growth factor (VEGF)-eluting stents

Int J Cardiol. 2003 Dec;92(2-3):247-51. doi: 10.1016/s0167-5273(03)00102-5.

Abstract

Background: Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen. It promotes re-endothelialisation of the damaged vessel surface seen after stenting. Stent thrombosis and in-stent restenosis are partly related to endothelial denudation caused by stent implantation. We propose using hydrocarbon polymer-coated stents immersed in VEGF to speed re-endothelialisation and reduce the risk of stent thrombosis and restenosis.

Methods: Stents (3 x 20 mm) were immersed in VEGF solutions and maximal VEGF absorption calculated. VEGF release from these stents was measured in a perfusion circuit. Delivery of VEGF to arterial wall was measured. Sterile VEGF-loaded stents were cultured with human umbilical vein endothelial cells.

Results: 18.5 +/- 4.1 microg VEGF was absorbed, 80% of which was released over 9 days; 11 +/- 6.8% of the initial VEGF loaded was delivered to the vessel wall. Cells exposed to VEGF-eluting stents showed an 11% increase in growth relative to controls.

Conclusion: VEGF may be a candidate for stent-based delivery and may increase the rate of endothelialisation in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Coronary Stenosis
  • Endothelium, Vascular / growth & development
  • Equipment Design
  • Humans
  • In Vitro Techniques
  • Stents*
  • Vascular Endothelial Growth Factor A / administration & dosage*
  • Vascular Endothelial Growth Factor A / pharmacology

Substances

  • Vascular Endothelial Growth Factor A